Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
2.80B | 2.70B | 2.18B | 526.63M | 457.70M | 437.50M | Gross Profit |
1.14B | 1.62B | 1.28B | 355.54M | 320.29M | 309.31M | EBIT |
411.88M | 471.22M | 1.18B | 124.89M | 123.09M | 124.70M | EBITDA |
1.59B | 1.61B | 1.19B | 314.54M | 280.96M | 1.13B | Net Income Common Stockholders |
279.10M | 243.14M | 306.01M | 37.80M | 25.40M | 10.20M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
157.16M | 119.82M | 138.99M | 7.73M | 9.88M | 2.52M | Total Assets |
20.54B | 19.94B | 15.70B | 5.10B | 5.18B | 4.41B | Total Debt |
9.30B | 9.02B | 7.08B | 1.92B | 2.02B | 1.51B | Net Debt |
9.14B | 8.90B | 6.97B | 1.92B | 2.01B | 1.51B | Total Liabilities |
10.94B | 10.88B | 8.77B | 2.10B | 2.19B | 1.67B | Stockholders Equity |
8.88B | 8.40B | 6.35B | 2.87B | 2.84B | 2.64B |
Cash Flow | Free Cash Flow | ||||
1.17B | 1.07B | 956.24M | 218.53M | 214.99M | 199.41M | Operating Cash Flow |
1.21B | 1.07B | 956.24M | 258.40M | 247.56M | 233.30M | Investing Cash Flow |
-255.20M | -113.80M | -576.75M | -38.47M | -603.22M | -201.91M | Financing Cash Flow |
-969.18M | -941.42M | -337.30M | -222.07M | 363.03M | -31.22M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $97.55B | 160.81 | 3.52% | 1.76% | 23.31% | 36.07% | |
76 Outperform | $4.15B | 29.52 | 5.15% | 6.88% | 7.81% | 179.16% | |
71 Outperform | $10.48B | 22.70 | 10.53% | 7.40% | 10.56% | 45.37% | |
69 Neutral | $11.97B | 42.44 | 3.26% | 7.16% | 23.65% | 12.82% | |
64 Neutral | $86.80B | 193.83 | 1.36% | 2.85% | 10.00% | ― | |
60 Neutral | $2.76B | 10.59 | 0.51% | 8507.90% | 5.51% | -19.44% | |
49 Neutral | $5.04B | ― | -6.83% | 8.64% | -7.26% | 18.45% |
John Thomas, Vice Chair of Healthpeak Properties, is set to participate in a panel discussion at the BofA Securities 2025 Healthcare Conference on May 14, 2025. This participation highlights Healthpeak’s ongoing engagement with industry events, potentially impacting its visibility and stakeholder relations.
The most recent analyst rating on (DOC) stock is a Buy with a $26.00 price target. To see the full list of analyst forecasts on Healthpeak Properties stock, see the DOC Stock Forecast page.
On January 30, 2025, Healthpeak Properties, Inc. adopted an Employee Stock Purchase Plan (ESPP) to allow eligible employees to purchase company stock at a discount, aligning their interests with those of shareholders. The ESPP was approved at the annual meeting on April 24, 2025, where all board nominees were elected, executive compensation was approved, and Deloitte & Touche LLP was ratified as the independent auditor.
On April 24, 2025, Healthpeak Properties appointed Kelvin O. Moses as Chief Financial Officer, effective immediately, as part of its succession plan. Moses, who joined Healthpeak in 2018 and has held various leadership roles, is expected to guide the company through its next growth phase, leveraging his strategic mindset and healthcare insight. His previous role involved leading the integration of a significant merger, establishing Healthpeak as the largest owner of outpatient medical real estate nationwide.
Healthpeak Properties reported its financial results for the first quarter of 2025, showing a net income of $0.06 per share and a 7.0% growth in Total Same-Store Portfolio Cash (Adjusted) NOI. The company declared a monthly cash dividend and entered a long-term partnership with Hines for a mixed-use development in Cambridge, Massachusetts. Healthpeak also issued $500 million in senior unsecured notes and repurchased 5.1 million shares, enhancing its liquidity and financial position.
On April 2, 2025, Peter A. Scott resigned as Chief Financial Officer of Healthpeak Properties, Inc. to become the CEO of Healthcare Realty Trust Incorporated. Healthpeak Properties expressed gratitude for Scott’s eight years of service, during which the company undertook significant portfolio and platform improvements. The company plans to announce an internal successor soon, ensuring a seamless transition and continued organizational impact.